REDPHARMA
REDPHARMA, officially known as REDPHARMA NV, is a prominent player in the pharmaceutical industry, headquartered in Belgium. Founded in 2005, the company has established itself as a leader in the development and distribution of high-quality generic medicines and innovative healthcare solutions across Europe and beyond. With a strong focus on therapeutic areas such as oncology, cardiology, and infectious diseases, REDPHARMA offers a diverse portfolio of products that stand out for their efficacy and safety. The company’s commitment to research and development has led to significant milestones, including partnerships with leading healthcare providers and regulatory bodies. Recognised for its dedication to quality and patient care, REDPHARMA continues to enhance its market position, striving to meet the evolving needs of healthcare professionals and patients alike.
DitchCarbon Score
How does REDPHARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
REDPHARMA's score of 6 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
REDPHARMA's reported carbon emissions
REDPHARMA, headquartered in Belgium, currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions statistics, it is important to note that REDPHARMA has not outlined any specific reduction targets or initiatives related to carbon emissions. This lack of publicly available information on climate commitments may reflect a broader industry context where many companies are increasingly focusing on sustainability and carbon neutrality. As the global emphasis on climate action intensifies, it is crucial for organisations like REDPHARMA to establish clear climate commitments and reduction strategies to align with industry standards and stakeholder expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
REDPHARMA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
